Literature DB >> 19766586

ADAM8 substrate specificity: influence of pH on pre-processing and proteoglycan degradation.

Troii Hall1, Lyle E Pegg, Adele M Pauley, H David Fischer, Alfredo G Tomasselli, Marc D Zack.   

Abstract

A disintegrin and metalloprotease-8 (ADAM8) is thought to play a role in cancer and inflammatory diseases such as allergy, arthritis, and asthma. Despite the implication of ADAM8 in these diseases, the functional role of ADAM8 catalytic activity remains unclear. In this report, we demonstrate that an early critical autolytic event, we have termed pre-processing, is accelerated at acidic pH (pH 5.5) while autolytic activation is abrogated under the same conditions. Likewise, we found that pre-processing is hindered and autolytic activation is facilitated in neutral pH conditions, and thus demonstrates a pH-dependent shift in substrate selectivity. This finding is further supported by two peptide substrates corresponding to the pre-processing and C-terminal scissile bonds that were preferentially cleaved at acidic and neutral pH, respectively. Lastly, we found fibronectin cleavage to be attenuated at pH 5.5, while two novel substrates, brevican, and vitronectin, were readily cleaved in neutral or acidic conditions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766586     DOI: 10.1016/j.abb.2009.09.005

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  4 in total

1.  Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates.

Authors:  Roma Stawikowska; Mare Cudic; Marc Giulianotti; Richard A Houghten; Gregg B Fields; Dmitriy Minond
Journal:  J Biol Chem       Date:  2013-06-18       Impact factor: 5.157

2.  Overexpression of a disintegrin and metalloprotease 8 in human gliomas is implicated in tumor progression and prognosis.

Authors:  Shiming He; Lianshu Ding; Yizhan Cao; Gang Li; Jianping Deng; Yanyang Tu; Boliang Wang
Journal:  Med Oncol       Date:  2011-10-09       Impact factor: 3.064

3.  Upregulation of a disintegrin and metalloprotease 8 influences tumor metastasis and prognosis in patients with osteosarcoma.

Authors:  Zhehai Li; Qiande Liao; Yuchi Wu; Mingmei Liao; Yuqin Hao; Shengbin Zhang; Shipeng Song; Bing Li; Yang-de Zhang
Journal:  Pathol Oncol Res       Date:  2012-01-05       Impact factor: 3.201

4.  Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates.

Authors:  Dmitriy Minond; Mare Cudic; Nina Bionda; Marc Giulianotti; Laura Maida; Richard A Houghten; Gregg B Fields
Journal:  J Biol Chem       Date:  2012-08-27       Impact factor: 5.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.